New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
10:00 EDTMHK, MTG, ETFC, SMI, XOOM, POT, MTH, HON, ATLS, HAFC, SALE, BTU, MRK, EIX, AGI, KSU, FMBI, PBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alamos Gold (AGI) upgraded to Outperform from Sector Perform at RBC Capital... Atlas Energy (ATLS) upgraded to Outperform from Neutral at RW Baird... E-Trade (ETFC) upgraded to Outperform from Market Perform at JMP Securities... Edison International (EIX) upgraded to Hold from Underperform at Jefferies... Honeywell (HON) upgraded to Buy from Hold at Lagenberg... MGIC Investment (MTG) upgraded to Outperform from Market Perform at JMP Securities... Merck (MRK) upgraded to Overweight from Underweight at Morgan Stanley... Meritage Homes (MTH) upgraded to Overweight from Equal Weight at Barclays... Mohawk (MHK) upgraded to Overweight from Neutral at JPMorgan... Peabody (BTU) upgraded to Neutral from Underperform at BofA/Merrill... Potash (POT) upgraded to Outperform from Market Perform at Raymond James... Prosperity Bancshares (PB) upgraded to Outperform from Market Perform at BMO Capital... RetailMeNot (SALE) upgraded to Buy from Neutral at Goldman... Xoom (XOOM) upgraded to Strong Buy from Market Perform at Raymond James... First Midwest (FMBI) upgraded to Outperform from Market Perform at Fig Partners... Hanmi Financial (HAFC) upgraded to Outperform from Market Perform at Keefe Bruyette... Semiconductor Manufacturing (SMI) upgraded to Buy from Sell at UBS... Kansas City Southern (KSU) upgraded to Neutral from Underperform at Buckingham.
News For AGI;ATLS;ETFC;EIX;HON;MTG;MRK;MTH;MHK;BTU;POT;PB;SALE;XOOM;FMBI;HAFC;SMI;KSU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 23, 2015
09:12 EDTHONIntelligent Highway Solutions completes purchase order from Honeywell
Subscribe for More Information
08:09 EDTHAFCHanmi Financial reports Q2 EPS 44c, consensus 37c
Subscribe for More Information
July 22, 2015
14:51 EDTSMIEarnings Watch: Qualcomm reports after speculations of potential breakup
Qualcomm (QCOM) is expected to report third quarter earnings after the close on July 22, with a conference call scheduled for 4:45 pm ET. Qualcomm is a maker of semiconductors and telecommunications equipment. EXPECTATIONS: Analysts are looking for earnings per share of 95c on revenue of $5.85B. EPS consensus ranges 90c-$1.05 on a revenue range of $5.59B-$6.08B, according to First Call. LAST QUARTER: On April 22, Qualcomm reported Q2 EPS of $1.40 against expectations for $1.33, and revenue of $6.89B versus estimates of $6.83B. The company also cut its FY15 EPS guidance to $4.60-$5.00 from $4.85-$5.05 and lowered projected revenue to $25B-$27B from $26.3B-$28B, saying it expects pressure in its semiconductor business due to customer shifts in the premium segment and a decline in Qualcomm's share at an unnamed large customer. NEWS: On May 8, Reuters reported that EU antitrust regulators asked Qualcomm's competitors how the company's licensing and business practices affect them, and on July 16, the European Commission confirmed two formal antitrust investigations of the company. On May 25, Qualcomm and Daimler (DDAIF) announced a strategic collaboration to develop connected car technology. Coming on the heels of Avago's (AVGO) May 28 agreement to acquire Broadcom (BRCM), Bloomberg quoted a source later that day as saying Qualcomm, Intel (INTC), Altera (ALTR), Analog Devices (ADI), Maxim Integrated (MXIM), Texas Instruments (TXN), and Microchip Technology (MCHP) are all considering their own M&A opportunities. Note that on June 1, Intel announced an agreement to acquire Altera. On June 23, Semiconductor Manufacturing International (SMI), Qualcomm, Huawei, and Imec announced the formation of a joint venture to focus on a type of 14 nanometer technology. More recently, the Wall Street Journal reported on July 20 that Qualcomm is "expected" to begin a comprehensive strategic review which may include the possibility of a breakup following pressure from "activist" shareholder Jana Partners, according to sources, adding that the move could be announced concurrent with Wednesday's earnings release. STREET RESEARCH: Following last quarter's earnings report, Exane BNP Paribas downgraded Qualcomm to Neutral from Outperform, while both Canaccord and Brean Capital lowered price targets for the stock after "disappointing" guidance. Meanwhile, Citi said it expects the company's chip business to recover in 2016 despite this "very bad year." On May 28, CLSA said it sees continued pressure on Qualcomm chipsets, potentially spurring the company to consider making an acquisition, and on June 2, Craig-Hallum noted that Skyworks (SWKS) would be a great fit for Qualcomm. On June 24, Summit Research called Applied Micro Circuits (AMCC) an "affordable" target for Qualcomm, with AMD (AMD) and Cavium (CAVM) also looking like potential takeover candidates. On June 29, Drexel Hamilton downgraded Qualcomm to Sell from Hold, citing expected price cuts. Lastly, following media reports on July 20 that Qualcomm could be weighing a breakup, Bernstein said that such a "dis-synergistic" split would likely destroy value rather than create it. PRICE ACTION: Shares of Qualcomm are down more than 1% to $64.37 in afternoon trading ahead of Wednesday's earnings report.
14:37 EDTMHKHome improvement stocks rally after Owens Corning results, home sales data
Subscribe for More Information
10:15 EDTMTGOptions with decreasing implied volatility
Subscribe for More Information
10:01 EDTBTUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:26 EDTPOTK+S preparing for possible hostile bid from Potash, Wirtschaftswoche reports
Subscribe for More Information
07:04 EDTMRKMerck's Keytruda approved by EU for treatment of advanced melanoma in adults
Merck announced that the European Commission has approved KEYTRUDA, the company’s anti-PD-1 therapy, for the treatment of advanced melanoma in adults. The European Commission approval of pembrolizumab is based on data from three clinical studies conducted in more than 1,500 first-line and previously-treated patients with advanced melanoma. Pembrolizumab received European Commission regulatory approval based on Phase 3 data which showed it is the first and only anti-PD-1 therapy to provide a statistically superior survival benefit as a monotherapy compared to ipilimumab, the current standard of care for advanced melanoma. Today’s approval allows marketing of pembrolizumab in all 28 EU member states at the approved dose of 2 mg/kg every three weeks. The European Commission’s approval is based on data from three studies -- KEYNOTE-001, KEYNOTE-002 and KEYNOTE-006. These studies evaluated the efficacy and safety of pembrolizumab in advanced melanoma patients – across treatment lines, prognostic factors, tumor characteristics, and BRAF mutational status – and established 2 mg/kg every three weeks as the approved dose.
06:23 EDTBTUPeabody downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:05 EDTMRKMerck, Ablynx expand immuno-oncology collaboration
Subscribe for More Information
July 21, 2015
18:45 EDTFMBIFirst Midwest reports Q2 EPS 29c, consensus 29c
Subscribe for More Information
13:14 EDTPOTK+S says new Potash offer not enough for takeover talks, Reuters says
Subscribe for More Information
10:24 EDTMTGOptions with decreasing implied volatility
Subscribe for More Information
10:14 EDTXOOMHigh option volume stocks:
Subscribe for More Information
09:06 EDTHONHoneywell's company technology selected by China's Ningxia Baota Chemical Fiber
UOP, a Honeywell company, announced that China's Ningxia Baota Chemical Fiber will use Honeywell UOP's latest generation technologies and equipment to build an energy-efficient petrochemical complex. The Yinchuan City, Ningxia, China, complex will produce valuable petrochemicals as well as high-quality gasoline, and is expected to come online in 2018. In addition to licensing, Honeywell UOP will provide the basic engineering, commissioning services, training services, proprietary equipment, catalysts and adsorbents for the new complex.
July 20, 2015
10:13 EDTMTGOptions with decreasing implied volatility
Subscribe for More Information
08:29 EDTHONHoneywell organic growth hurdles could lead to M&A, says Cowen
Cowen believes Honeywell (HON) faces many hurdles to its organic growth, which could lead to M&A activity. The firm believes Honeywell targets could include Teledyne (TDY), BE Aerospace (BEAV) or Astronics (ATRO), which would allow it to grow it market leading telematics position. Cowen reiterated its Outperform rating and $116 price target on Honeywell shares.
07:51 EDTKSUKansas City Southern upside attractive, says UBS
Subscribe for More Information
07:12 EDTHONHoneywell reported strong operating results, says Stifel
Subscribe for More Information
06:00 EDTBTUStocks with implied volatility movement; BTU MRVL
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use